metastatic castration-resistant prostate cancer

You have access
Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with ²²³Ra Therapy in Daily Practice
Joost H.H.M. van Riel, Maarten L. Donswijk, Christel Brouwer, Winald R. Gerritsen, T.T. Ha Tan-Phan, Paul W.L. Thimister, Walter Noordzij, Erik T. Te Beek, Laurence J.C. van Warmerdam, Andries M. Bergman, Inge M. van Oort, Dirk N.J. Wyndaele and Maarten J. van der Doelen

Journal of Nuclear Medicine May 22, 2025, jnumed.125.269746; DOI: https://doi.org/10.2967/jnumed.125.269746
You have access
A Phase I/II Study of [¹⁷⁷Lu]Lu-HTK03170 with Personalized Dosimetry in Patients with Metastatic Castration-Resistant Prostate Cancer: Clinical Trial Protocol
Sara Harsini, Maryam Soleimani, Don Wilson, Carlos Uribe, Heather Saprunoff, Ingrid Bloise and Francois Benard

Journal of Nuclear Medicine April 30, 2025, jnumed.124.269064; DOI: https://doi.org/10.2967/jnumed.124.269064
You have access
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [¹⁷⁷Lu]Lu-PSMA-617
Miguel Muniz, Oliver Sartor, Jacob J. Orme, Regina M. Koch, Hana R. Rosenow, Ahmed M. Mahmoud, Jack R. Andrews, Adam M. Kase, Irbaz B. Riaz, Gokce Belge Bilgin, Matthew P. Thorpe, A. Tuba Kendi, Geoffrey B. Johnson, Praful Ravi, Eugene D. Kwon and Daniel S. Childs

Journal of Nuclear Medicine December 1, 2024, 65 (12) 1932-1938; DOI: https://doi.org/10.2967/jnumed.124.268277
Open Access
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy
Jeremie Calais, Michael J. Morris, Ayse Tuba Kendi, Arash Rezazadeh Kalebasty, Ronald Tutrone, Michael J. Anderson and Oliver Sartor

Journal of Nuclear Medicine November 1, 2024, 65 (11) 1666-1671; DOI: https://doi.org/10.2967/jnumed.124.268363
Open Access
Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study
Frédéric Pouliot, Fred Saad, Etienne Rousseau, Patrick O. Richard, Atefeh Zamanian, Stephan Probst, Éric Lévesque, Vincent Castonguay, Nicolas Marcoux, Michele Lodde, Daniel Juneau, Zineb Hamilou, Jean-Baptiste Lattouf, François-Alexandre Buteau, Michel Pavic, Jean-François Castilloux, Bertrand Neveu, Guillaume F. Bouvet, Catherine Allard, Amélie Tétu, Brigitte Guérin, Jean-Mathieu Beauregard and for the 3TMPO Investigators

Journal of Nuclear Medicine November 1, 2024, 65 (11) 1710-1717; DOI: https://doi.org/10.2967/jnumed.124.268020
You have access
Initial Experience with [¹⁷⁷Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction
Andrei Gafita, Andrew Voter, Somya Shesadri, Avery Spitz, Catherine H. Marshall, Steven P. Rowe, Mark C. Markowski, Martin G. Pomper, A. Cahid Civelek, Michael A. Carducci, Samuel R. Denmeade, Jeffrey Young, Kenneth J. Pienta, Channing J. Paller and Lilja B. Solnes

Journal of Nuclear Medicine November 1, 2024, 65 (11) 1724-1730; DOI: https://doi.org/10.2967/jnumed.124.267723
You have access
Impact of Posttreatment SPECT/CT on Patient Management During ¹⁷⁷Lu-PSMA-617 Radiopharmaceutical Therapy
Surekha Yadav, Blair Lowery, Abuzar Moradi Tuchayi, Fei Jiang, Rachelle Saelee, Rahul R. Aggarwal, Roxanna Juarez, Robert R. Flavell and Thomas A. Hope

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1395-1401; DOI: https://doi.org/10.2967/jnumed.124.267955
You have access
RECIP 1.0 Predicts Progression-Free Survival After [¹⁷⁷Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
Andrei Gafita, Loic Djaileb, Isabel Rauscher, Wolfgang P. Fendler, Boris Hadaschik, Steven P. Rowe, Ken Herrmann, Lilja B. Solnes, Jeremie Calais, Matthew B. Rettig, Manuel Weber, Andrea Farolfi, Matthias R. Benz and Matthias Eiber

Journal of Nuclear Medicine June 1, 2024, 65 (6) 917-922; DOI: https://doi.org/10.2967/jnumed.123.267234
Open Access
Renal and Multiorgan Safety of ¹⁷⁷Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
Ken Herrmann, Kambiz Rahbar, Matthias Eiber, Richard Sparks, Nicholas Baca, Bernd J. Krause, Michael Lassmann, Walter Jentzen, Jun Tang, Daniela Chicco, Patrick Klein, Lars Blumenstein, Jean-René Basque and Jens Kurth

Journal of Nuclear Medicine January 1, 2024, 65 (1) 71-78; DOI: https://doi.org/10.2967/jnumed.123.265448
Open Access
¹⁷⁷Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior ²²³Ra (RALU Study)
Kambiz Rahbar, Markus Essler, Matthias Eiber, Christian la Fougère, Vikas Prasad, Wolfgang P. Fendler, Philipp Rassek, Ergela Hasa, Helmut Dittmann, Ralph A. Bundschuh, Kim M. Pabst, Milena Kurtinecz, Anja Schmall, Frank Verholen and Oliver Sartor

Journal of Nuclear Medicine December 1, 2023, 64 (12) 1925-1931; DOI: https://doi.org/10.2967/jnumed.123.266125

Main menu

User menu

Search

metastatic castration-resistant prostate cancer

Pages